Pharmafile Logo
Pharmafocus logo
Advanced Search

Androlabs

Showing 3 posts of 3 posts found.

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026
Androlabs, Testavan, UK authorisation, hypogonadism, testosterone

Androlabs has received UK marketing authorisation for a new presentation of Testavan 4.6 mg/actuation transdermal gel for testosterone replacement therapy …

News

Androlabs and Majorelle expand testosterone therapy into France

August 4, 2026
Androlabs, Majorelle, hypogonadism, testosterone therapy

Androlabs has partnered with French men’s health specialist Majorelle to commercialise Testavan, a testosterone replacement therapy for adult men with …

News

Mind the gap: men’s health and the need for progress

May 12, 2025
Advocacy Development, Medical Communications, Medical Education, Research and Development Androlabs, Men's Health Strategy, Men's mental health, Movember Foundation, Pharmacy, Psychiatry, mental health

From prostate cancer to hormonal health, many areas of men’s health require more attention. As male life expectancy and healthy …

Feature
Thought Leadership
The Gateway to Local Adoption Series

Latest content

Cori Clinical raises US$4m to expand AI platform for clinical trial design

October 14, 2026

Ofichem acquires US drug substance CDMO Kinentia

October 14, 2026

Jager-van Dijk is new Arletta Pharma Solutions CEO 

October 13, 2026

Tridem begins phase Ib trial of Parkinson’s disease vaccine

October 13, 2026

Bio-Techne opens GMP small-molecule manufacturing facility in Bristol

October 13, 2026